|
Apr 2
|
Gilead Sciences (GILD) Dips More Than Broader Market: What You Should Know
|
|
Mar 28
|
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
|
|
Mar 28
|
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
|
|
Mar 28
|
Gilead bets on Xilio cancer drug as biotech restructures
|
|
Mar 28
|
7 Value Stocks to Buy at a 52-Week Low in March
|
|
Mar 26
|
Winn Awards Help Physicians Solve Healthcare Disparities
|
|
Mar 26
|
20 Biggest Health Care Companies in Australia, 2024
|
|
Mar 25
|
Gilead Sciences (GILD) Stock Moves -0.04%: What You Should Know
|
|
Mar 22
|
Gilead Sciences Announces Completion of Acquisition of CymaBay
|
|
Mar 21
|
Why Is Axsome (AXSM) Down 4% Since Last Earnings Report?
|
|
Mar 20
|
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
|
|
Mar 19
|
Gilead Sciences (GILD) Rises But Trails Market: What Investors Should Know
|
|
Mar 19
|
Gilead Helps Launch Türkiye’s First HIV Testing Week
|
|
Mar 18
|
Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
|
|
Mar 17
|
11 Oversold Biotech Stocks To Buy Right Now
|
|
Mar 17
|
2 Top Dividend Stocks to Buy Hand Over Fist
|
|
Mar 15
|
Gilead CAR-T cancer therapy capacity to quadruple by 2026
|
|
Mar 14
|
12 Most Profitable Biotech Stocks To Invest In
|
|
Mar 13
|
Gilead Sciences Inc's Dividend Analysis
|
|
Mar 11
|
Gilead Sciences' (NASDAQ:GILD) Shareholders Will Receive A Bigger Dividend Than Last Year
|